If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAthelney Tst. Regulatory News (ATY)

Share Price Information for Athelney Tst. (ATY)

Share Price is delayed by 15 minutes
Get Live Data
165.00    0.00 (0.00%)
Bid:
140.00
Ask:
190.00
Spread: 50.00 (35.714%)
Market Cap: £3.56m
ATY Live PriceLast checked at - London Stock Exchange

Intraday Athelney Tst. Share Chart

Letter to Shareholders

18 Mar 2019 09:05

RNS Number : 1576T
Athelney Trust PLC
18 March 2019
 

Dear Fellow Shareholders

 

I am writing to you ahead of the Annual General Meeting on 3 April 2019 when we will all be voting on resolutions required in terms of the Companies Act and a few that I have proposed. The purpose of this letter is to explain my reasons for the additional agenda items and why I believe we should remove the current Board in its entirety, appoint Simon to the Board and definitely not authorise the issue of any shares by the current directors.

 

In essence my rationale for these recommendations is based on the following observations:

· There is zero alignment of interest between the current directors, Gresham House (who recommended their appointment) and the shareholders of Athelney. Gresham House clearly have their own agenda to pursue and none of the current directors' have taken the time to acquaint themselves with the other Athelney shareholders as Simon Moore had done during his brief stint as a director and Chairman. Furthermore, as far as I am aware, neither Gresham House nor any of the current directors own any shares in Athelney, a requirement in any small company to ensure alignment of interest.

· Athelney has always been an extremely well-run Investment Trust with a low-cost structure and a compliance regime suitable for a small company. It would appear that the current directors have increased the cost base with increased travel and consultant fees, using corporate governance as the reason which is modern parlance for a complete lack of experience in the running of the relevant business.

· In a recent Royal Commission into the Financial Services Industry, Justice Haynes found that the poor performance of financial institutions was due to a failure at Board level to ensure an appropriate culture, governance structure and remuneration system. While he confirmed that Boards of Companies are responsible to shareholders, they also have an obligation to all stakeholders such as employees, service providers and customers and more importantly, in the execution of their duties the Boards cannot and must not involve themselves in the day to day management of the Corporation. The current board, in spite of having no meaningful funds management experience, have on a number of occasions attempted to interfere in both stock selection and asset selection, both of which are not the responsibility of the board but of the investment manager, not only contractually but also as indicated by Justice Haynes as a requirement to ensure good corporate governance.

· Athelney has always had a culture best described as one of a personalised touch, provided not only by Robin Boyle but also by John Girdlestone and his team at GW & Co. The current sidelining by the Board of GW & Co with the clear intention of replacing them by a larger firm, implies that their many years of amazing service to Athelney actually means nothing. I find this disgraceful, destroying the firm culture and also contrary to the findings of Justice Haynes.

· Simon Moore has a long career in investment trusts and has a strong reputation in the sector. He will bring a deep understanding of Athelney Trust, fellow shareholders, other stakeholders and the technical details required of running an investment trust, all of which the current board lack.

· I have made an offer to Robin to work with Simon and I over the next two years to bring about an orderly transition and have received no response.

 

The annual report contains a detailed explanation of our approach to investing. In addition, I urge shareholders to google my name to see what I stand for and what I have accomplished. I hope you will consider what I have to say and vote as I suggest.

 

Yours faithfully,

 

Dr Manny Pohl B.Sc (Eng), MBA, DBA, FAICD, MSAFAA, F Fin

4 March 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NOAJPMPTMBABMRL
Date   Source Headline
25th Jan 20191:37 pmRNSDirectorate Change
25th Jan 201910:08 amRNSDirectorate Change
22nd Jan 20192:52 pmRNSResult of EGM
11th Jan 20193:00 pmRNSEGM Shareholder Statement
4th Jan 201910:26 amRNSNet Asset Value(s)
28th Dec 20184:00 pmRNSNotice of Extraordinary General Meeting
19th Dec 20181:43 pmRNSDirector/PDMR Shareholding
19th Dec 20189:09 amRNSDirector/PDMR Shareholding
17th Dec 201811:28 amRNSStatement re Corporate Action
5th Dec 201810:43 amRNSNet Asset Value(s)
3rd Dec 20189:38 amRNSDirectorate Change
5th Nov 20189:39 amRNSNet Asset Value(s)
3rd Oct 20183:20 pmRNSNet Asset Value(s)
1st Oct 201811:43 amRNSDirectorate Change
5th Sep 201810:54 amRNSNet Asset Value(s)
3rd Aug 20188:30 amRNSNet Asset Value(s)
20th Jul 20187:00 amRNSHalf-year Report
4th Jul 20189:48 amRNSNet Asset Value(s)
25th Jun 20189:15 amRNSChange of Adviser
4th Jun 201812:52 pmRNSNet Asset Value(s)
2nd May 20182:12 pmRNSNet Asset Value(s)
30th Apr 20182:03 pmRNSDirectorate Change
16th Apr 20188:54 amRNSDirector/PDMR Shareholding
9th Apr 201811:35 amRNSNet Asset Value(s)
22nd Mar 201810:14 amRNSAGM Statement
6th Mar 201812:50 pmRNSNet Asset Value(s)
16th Feb 20187:00 amRNSAnnual Financial Report
6th Feb 20189:05 amRNSNet Asset Value(s)
3rd Jan 201810:51 amRNSNet Asset Value(s)
5th Dec 201710:15 amRNSNet Asset Value(s)
2nd Nov 201712:52 pmRNSNet Asset Value(s)
3rd Oct 201711:24 amRNSNet Asset Value(s)
4th Sep 201712:00 pmRNSNet Asset Value(s)
3rd Aug 20178:34 amRNSNet Asset Value(s)
25th Jul 20177:00 amRNSHalf-year Report
5th Jul 201710:59 amRNSNet Asset Value(s)
5th Jul 20179:53 amRNSHolding(s) in Company
5th Jun 20179:51 amRNSNet Asset Value(s)
8th May 20179:20 amRNSNet Asset Value(s)
5th Apr 20179:16 amRNSNet Asset Value(s)
31st Mar 201711:52 amRNSAGM Statement
6th Mar 20179:53 amRNSNet Asset Value(s)
24th Feb 20177:00 amRNSAnnual Financial Report
3rd Feb 201712:17 pmRNSNet Asset Value(s)
6th Jan 20178:54 amRNSNet Asset Value(s)
5th Dec 20169:13 amRNSNet Asset Value(s)
3rd Nov 20168:45 amRNSNet Asset Value(s)
4th Oct 20169:34 amRNSNet Asset Value(s)
21st Sep 20169:44 amRNSDirector/PDMR Shareholding
2nd Sep 201612:35 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.